Where does refractory collide?

In physiology, the refractory period is the short interval after an excitable cell fires an action potential during which it cannot be re-excited at all (the absolute refractory period) and then can be re-excited only by a stronger stimulus (the relative refractory period). Hodgkin and Huxley's 1952 A quantitative description of membrane current and its application to conduction and excitation in nerve traced this recovery to the inactivation of sodium channels and the delayed potassium conductance, so that excitability returns only as the membrane resets. The referent is a recovery interval in the electrical state of a nerve or muscle cell, measured in milliseconds, and it has nothing to do with a heat-resistant brick or a disease that resists treatment beyond the shared meaning of being, for a moment, unresponsive.[1]

Unit

The interval, in milliseconds, before an excitable cell can fire again

Recovery means

Excitability returns as sodium-channel inactivation lifts and the membrane repolarises to rest

Measured by

Measured by paired-pulse stimulation, tracking the recovery of action-potential threshold and amplitude over time

In clinical medicine, a refractory (or treatment-refractory) condition is a disease that fails to respond adequately to standard therapies, so that seizures, depression, hypertension, or a cancer persists despite treatments that control it in most patients. Kwan and colleagues' 2010 Definition of drug resistant epilepsy, the ILAE consensus proposal, gives the paradigm case a precise threshold: failure of two appropriately chosen and tolerated drug schedules to achieve sustained seizure freedom. The referent is a clinical category of non-response defined against a treatment standard, tracked by outcome after adequate trials, and it is unrelated to the millisecond recovery of a nerve or the heat tolerance of a ceramic, sharing only the meaning of stubborn resistance.[2]

Unit

Persistence of disease after an adequate trial of standard treatment

Recovery means

Some refractory disease responds to later-line or combination therapy; the label marks failure of the standard course, not permanence

Measured by

Established by documented failure of a defined number of adequate, tolerated standard treatments to reach the target outcome